LIGAND PHARMACEUTICALS INCORPORATED
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2023
Total Assets: $787.2M
Liabilities Breakdown FY2023
Total Liabilities: $86.3M
Asset Breakdown
Total Assets: $787.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $23.0M | 2.9% |
| Accounts Receivable | $32.9M | 4.2% |
| Inventory | $24.0M | 3.0% |
| Property, Plant & Equipment | $15.6M | 2.0% |
| Goodwill | $103.4M | 13.1% |
| Intangible Assets | $299.6M | 38.1% |
| Other Assets | $288.8M | 36.7% |
Liabilities Breakdown
Total Liabilities: $86.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.4M | 2.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $83.9M | 97.2% |